DIRS.INFO The most relevant business & tech news

☆ Palo Alto nears a key test that could break it out of Wall Street's penalty box
▼ + stars: | 2024-05-15 | by ( Morgan Chittum | ) www.cnbc.com time to read: +8 min

Shares of Palo Alto plunged 28% on Feb. 21, a session after the company delivered a more cautious outlook for the rest of 2024. The shift in business strategy requires Palo Alto to give customers its new services and products for free to demonstrate their many benefits. PANW YTD mountain Palo Alto Networks (PANW) year-to-date performance 2. The Club is focused on how much industry spend is going to Palo Alto versus competitors, but we're not concerned about demand for the company's offerings. In this photo illustration the Palo Alto Networks logo seen displayed on a smartphone and on the background.

Persons: Morgan Stanley, Sellers, Nikesh Arora, Palo, We'd, it's, PANW, Arora, Jim Cramer, We've, nudging, Stephen Vintz, we're, Jim, Jim Cramer's, Rafael Henrique Organizations: Palo Alto Networks, Wall Street, Palo, Tech, Barclays, Palo Alto, billings, Wall, Alto Networks, UnitedHealth Group, Change, Healthcare, Club, Microsoft, Vans, Corp, Caesars Entertainment, Securities, Exchange, US Fed, CNBC, Networks, Getty Locations: Palo Alto, U.S, Palo, billings, Palo Alto's, Alto

☆ Why America Still Can't Get Rid of High Prices, Inflation
▼ + stars: | 2024-05-13 | by ( Neil Dutta | ) www.businessinsider.com time to read: +9 min

Typically, price increases are a slow-moving process, so it is rare to see core inflation accelerate this much this quickly. The Survey of Professional Forecasters has found longer-run expectations for inflation have leveled out at 2% — the Fed's target. These one-offs have had an outsize impact on the overall inflation picture. Ahead of 2024, the contribution from acyclical components to core inflation was essentially zero. The strong growth in private demand suggests that second-quarter GDP could be even more robust.

Persons: I've Organizations: America, Federal Reserve, PCE, Atlanta Fed Locations: Real

☆ 10 things you should be negotiating every time you land a job offer, according to ex-Microsoft HR VP
▼ + stars: | 2024-05-02 | by ( Chris Williams | ) www.businessinsider.com time to read: +7 min

Read previewAs a 40-plus-year veteran of the corporate world and the former VP of HR at Microsoft, I've seen a lot of people successfully negotiate their job offers. They want youThe most important thing to understand in the job hunt is that by the time you see an offer, they want you. They've made the offer a little slimmer than they expect to end up because they know there will be movement. It's not all about base payWhen most people think about negotiating a job offer, they often think about base pay, or the salary or hourly rate. So negotiate that job offer, and get what you deserve.

Persons: —, I've, They've, you've, It's, you'll, hasn't, they'll Organizations: Service, Microsoft, Business, Companies

☆ Hospital wait times will still be bad this year, even with labor gains
▼ + stars: | 2024-04-19 | by ( Allie Kelly | ) www.businessinsider.com time to read: +6 min

Small businesses are seeing labor growth this year, but hospitals still have staffing shortages. Healthcare worker numbers are steadily growing but remain below pre-pandemic trends, according to a Bank of America report published in April. Outpatient care centers are 9.4% behind on growth, while the hospital labor force has seen small gains at 0.3%. In fact, healthcare workers made up a significant portion of the people leaving their jobs during the Great Resignation. Patients will still see labor shortages in ERs and care facilitiesDespite labor gains, patients could still experience the impacts of the physician shortage.

Persons: —, Per, KFF Organizations: Service, Bank of America, The Bank of America Institute, of Labor Statistics, Centers, Medicare, Services, Kaiser Family Foundation, American Hospital Association, of America, Peterson Center, Healthcare, of Health, Bank of

☆ Earnings season is here. These are the biggest storylines the market is watching.
▼ + stars: | 2024-04-15 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +8 min

JPMorgan CEO Jamie Dimon issued a warning in the bank's earnings report Friday. With so much at stake, here's an earnings season cheat sheet of when some of the biggest companies are reporting and the storylines to follow. Themes to watch: AI could reduce the number of junior bank employees thanks to the tech automating their grunt work . Themes to watch: Netflix was dubbed the king of streaming earlier this year after a big earnings report. The bank's earnings report beat analysts' expectations, but advisory revenues were down 21% year-over-year.

Persons: —, Donald Trump's, iStock, Rebecca Zisser, Jamie Dimon, Dimon, Michael M, Goldman Sachs, Blackstone, Will Meta, Bob Iger's, Brooks Kraft, Jeremy Barnum, it's, Jeff Currie, Justin Sullivan, Tesla, Elon Musk, Musk, Marco Bottigelli, Yevgen Romanenko, Tyler Le, Michelle Grisé, Dan DeFrancesco, Jordan Parker Erb, Hallam Bullock, George Glover, Grace Lett Organizations: Service, Business, JPMorgan . Tech, JPMorgan, New York Stock Exchange, Finance Key Companies, Bank of America, Companies, Meta, Microsoft, Apple, Nvidia, Amazon, Retail, Walmart, Costco, Netflix, Disney, Paramount Global, Boeing, Brooks Kraft LLC, Getty, BI, Healthcare, RAND, Boston Marathon Locations: Israel, Russia, United States, New York, London, Chicago

☆ A woman who suffered a brain injury after a fall lost out on $750,000 compensation after a judge branded her 'dishonest'
▼ + stars: | 2024-04-14 | by ( Cameron Manley | ) www.businessinsider.com time to read: +3 min

download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewA woman who suffered a brain injury after falling from a seaside pier lost out on $750,000 in compensation after she was found to be "thoroughly dishonest" in her claim, said a judge. In the US, an estimated $308.6 billion annually is lost to insurance fraudulent insurance claims, according to Forbes. Healthcare insurance fraud (including Medicaid and Medicare insurance fraud) is the most common type, estimated at $105 billion annually. But Ritchie said that "overall" he found Williams-Henry to have been "dishonest and manipulative," so he could dismiss the case.

Persons: —, Kirsty Williams, Henry, Williams, division's, Ritchie, Christel Williams, Ms Williams Organizations: Service, Aberavon Pier, Business, British Ports Holdings, Forbes . Healthcare Locations: Cardiff

☆ US scientists are leaving academia. That’s bad news for drug companies
▼ + stars: | 2024-04-01 | by ( Eva Rothenberg | ) edition.cnn.com time to read: +5 min

“Science postdocs perform the science,” Donna Ginther, an economist who studies the science labor market at the University of Kansas, told CNN. Biomedical companies take scientific contributions and, over time, aggregate them into a commercial product. Building on the discovery of mRNA in the 1960’s, the technology behind an mRNA vaccine for humans was in development for decades before the Covid-19 vaccine was first administered in 2020. By using that technology to develop their mRNA vaccines for Covid-19, pharmaceutical companies like Pfizer and Moderna made a windfall in profits. “That’s how they make money is through commercialization: they have a product, which they then patent and sell.”Why are scientists leaving academic labs?

Persons: postdocs, Donna Ginther, “ They’re, Michael Ciaglo, ”, “, Nobel, Dr, Katalin Kariko, ” Ginther, they’re, Ginther Organizations: New, New York CNN —, National Institutes of Health, NIH, National Science Foundation, University of Kansas, CNN, ”, Pfizer, Moderna, Wired Magazine, NSF, World Health Organization Locations: New York, United States, Denver , Colorado, Europe, Alzheimer’s

☆ Here's the 16-slide pitch deck addiction care startup Pelago used to raise $58 million
▼ + stars: | 2024-04-01 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +4 min

Healthtech startup Pelago just grabbed a fresh round of funding to power its own push. The Series C was an upround for Pelago, said Dr. Yusuf Sherwani, cofounder and CEO. Sherwani said the Series C round may be Pelago's last capital raise before it hopes to IPO. With the Series C funding, Pelago plans to launch a program in the second quarter of the year to refer members who don't complete substance use disorder treatment to inpatient facilities. Check out the 16-slide pitch deck Pelago used to raise a $58 million Series C.

Persons: —, Atomico, Yusuf Sherwani, Sherwani, Pelago, Phillips, we've Organizations: Service, Octopus Ventures, Business, Mental Health Services Administration, Healthcare, Centers for Disease Control, MetLife, GE Appliances, Pelago Locations: Pelago

☆ 'Nearing exhaustion': Top strategists warn that weaker consumer spending could cause US stocks to run out of steam — but 22 investments can thrive during a market reversal
▼ + stars: | 2024-03-16 | by ( James Faris | ) www.businessinsider.com time to read: +10 min

Eight economists, investment chiefs, and strategists that Business Insider recently spoke to credited healthier-than-anticipated consumer balance sheets and spending for the continued expansion. "Either that, or they're going to be maxed out — they can't get any more money. They're not going to have any liquidity to be able to continue to do the things they're going to do." He's also sticking with defensive stocks as consumer spending softens, including those in the consumer staples sector like Clorox (CLX) and Procter & Gamble (PG). Real estate is a "hated asset class" that's negatively correlated with interest rates, Sekera said.

Persons: shouldn't, Kevin Gordon, Charles Schwab, they're, Sue Crotty, Ed Clissold, Ned Davis, Clark Bellin, Bellin, David Rosenberg, They're, Rob Swanke, Swanke, Preston Caldwell, Morningstar's, Dave Sekera, Sekera, Christopher Barto, Gordon, Clissold, He's, Morningstar's Sekera, Crotty, Segal Marco Advisors, She's, Barto, that's Organizations: Business, Consumers, Segal Marco, Ned, Ned Davis Research, Commonwealth Financial Network, Nasdaq, Morningstar, Fort Pitt Capital Group, Procter, Gamble, Federal Reserve, Exxon, APA Corp, Duke Energy, Segal, Energy, Healthcare Locations: Devon, Real, NiSource

☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
▼ + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.

Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly

☆ This sector offers defensive and growth properties – along with some portfolio income
▼ + stars: | 2024-02-26 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +6 min

The health-care sector of the S & P 500 is up about 8% year to date, marking a sharp comeback from a largely flat 2023. Even as health care is making a comeback this year, investors shouldn't forget its defensive attributes. Back in 2022, when the S & P 500 fell 19.4%, the health-care sector slipped only 3.5% "When markets are challenged, health care can be a good place to be," Lyons added. Some of them speak to the growth aspects of health care and why you can play offense." Merger activity is another driver of growth in health care, as large pharmaceutical companies snap up nimble biotech firms that are at the forefront of developing treatments.

Persons: Dan Lyons, Janus Henderson, shouldn't, Lyons, ImmunoGen, Seamus Fernandez, Sotatercept, Cigna, Cantor Fitzgerald, Sarah James, Fred Imbert Organizations: Big Tech, . Healthcare, Janus, Janus Henderson Investors, U.S . Food, Drug Administration's Center, Drug, Research, FDA, Esai, Pharmaceuticals, CNBC Pro, Merck, Abbott Laboratories, AbbVie, CVS Health Locations: U.S

☆ 'There's very little margin for error': 7 strategists explain why the Goldilocks narrative is in trouble — but these 8 investments are still worth making now
▼ + stars: | 2024-02-16 | by ( James Faris | ) www.businessinsider.com time to read: +9 min

Investors are pricing in a best-case outcome where earnings rise and inflation returns to normal in a continued economic expansion. “It’s a tough needle to thread,” said Steve Sosnick, the chief strategist at Interactive Brokers. “And that pretty much pulls forward almost all the returns, in our minds, for 2024.”AdvertisementCrit Thomas, a global market strategist at Touchstone Investments, has the same concern. “And so at 21x earnings, there’s very little margin for error here.”AdvertisementFourth-quarter earnings mostly met measured expectations , as did forward guidance. Clark Bellin, the chief investment officer at Bellwether Wealth, said he’s less worried about valuations broadly and is more interested in seeing which sectors look cheap.

Persons: —, ”, Solita Marcelli, “, Sameer Samana, Steve Sosnick, It’s, Steven Wieting, “ We’ve, Crit Thomas, “ I’m, ” Thomas, We’re, Chris Galipeau, ” Galipeau, ” Sosnick, we’ve, Liz Ann Sonders, Schwab, ” Sonders, there’s, Clark Bellin, he’s, ” Bellin, you’re, Stocks, Samana, won’t, Thomas, Wieting, Bellin, “ They’ve, they’re Organizations: Service, Business, UBS Global Wealth Management, Federal Reserve, Wells, Wells Fargo Investment Institute, Interactive, Citi Global Wealth’s, Touchstone Investments, Franklin Templeton Institute, Citi Global Wealth, Bellwether Wealth Locations: Wells Fargo, Samana, ” Samana, Galipeau

☆ Nvidia's investment in startups has nearly tripled as other tech heavyweights pull back
▼ + stars: | 2024-01-31 | by ( Filip De Mott | ) www.businessinsider.com time to read: +2 min

Nvidia's blowout performance last year has helped cement the firm as a rising star in corporate venturing, with the chipmaker's startup investments having nearly tripled in 2023, S&P Global reported on Tuesday. Pullbacks also extend to other firms that are historically leaders in corporate venturing, such as SoftBank Group and Tencent Holdings. The total value of rounds surpasses $5 billion, S&P Global cited. The firm's 2022 termination of a deal to acquire Arm Holdings suggests that bigger M&A deals are off the table, S&P Global said. For 2024, the chipmaker doesn't seem to be slowing down; its already announced three startup investments, S&P Global said.

Persons: Pullbacks, Nvidia's Organizations: P Global, Microsoft, Facebook, Business, SoftBank, Tencent Holdings, IBM, Amazon, Nvidia, Arm Holdings, Healthcare

☆ Fat Joe on teaming up with Jelly Roll and Wyclef Jean to advocate for healthcare price transparency in Washington, DC
▼ + stars: | 2024-01-17 | by ( John Lynch | ) www.businessinsider.com time to read: +12 min

Around 500 Congress members and government officials attended to watch Joe perform with artists Jelly Roll and Wyclef Jean, according to the artist's rep. You know, I'm an open book. Jelly Roll, Fat Joe, and Wyclef Jean. Power to the Patients/Shareif ZiyadatWhat made Jelly Roll and Wyclef Jean the right folk to link with on this particular event? AdvertisementAnd this year, you know, I'm a huge fan of Jelly Roll.

Persons: Joe, Hakeem Jeffries, Frank Pallone, Sen, Mike Braun, Jelly Roll, Wyclef Jean, Power, Chuck D, Busta, Rick Ross, who's, Kevin Morra, He's, we've, Cynthia Fisher, Uber, I'm, Brown, I've, Wycelf Jean, Wyclef Jean . Power, Roll, they've, Wyclef, Donald Trump, it's Organizations: Power, Capitol, Democratic, Hamilton, Price, Joe, MTV, Healthcare, Republican, American Express Locations: Washington , DC, America, There's, Washington, Kentucky, French Montana, Haiti

☆ 'A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks
▼ + stars: | 2024-01-17 | by ( Weizhen Tan | ) www.cnbc.com time to read: +4 min

2023 wasn't a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. But now, Citi believes that "astute investors may find themselves with a trove of rebound opportunities." Citi's top picks in biotech include Biomea Fusion , Alnylam Pharmaceuticals , and Immunovant . Jared Holz, health-care sector strategist at Mizuho Securities Americas, named biotech firm Biogen as one of his top trading ideas for 2024. "Biotech has commanded everyone's attention, but the recovery of many best-in-class medical device companies post the GLP-1 selloff has been remarkable," Orton said.

Persons: There's, Jared Holz, Biogen, Trent, medtech, Matt Orton, Orton Organizations: Citi Global Wealth Investments, U.S . Healthcare, Citi, Biomea, Alnylam Pharmaceuticals, Mizuho Securities Americas, Biogen, medtech, Raymond James Investment Management, Medical, Biotech, Abbott Laboratories Locations: U.S, Alphinity, medtech

☆ Dud IPO market closes 2023 with a whimper for the second year in a row
▼ + stars: | 2023-12-08 | by ( Bob Pisani | ) www.cnbc.com time to read: +8 min

Another year, another lousy IPO market. The 2023 IPO market is closing with a whimper, not a bang. You'd think the IPO market would be bubbling, but it's dead quiet. Source: Renaissance Capital For a good part of the year, the excuse was interest rates were rising, the market was too volatile, and the after market performance of 2023 IPOs was terrible. The November rally is too little too late to save the IPO market Unfortunately, it all came a little too late to rescue 2023.

Persons: Birkenstock, You'd, Rivian, Doordash, IPOs, Matt Kennedy, Don Short, you've, haven't, confidentially, Waystar, Kim Kardashian's, Musk, Howe Ng, Ng, Kyle Stanford, Instacart, it's, James Ulan, Stanford, Pitchbook, Greg Martin Organizations: Renaissance, That's, IPOs, Hertz, Sotera, ARM, Renaissance Capital, Klarna, Microsoft, Forge Global, Bloomberg, SpaceX, Nvidia, Rainmaker Securities Locations: Pitchbook

☆ Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
▼ + stars: | 2023-12-01 | by ( ) www.reuters.com time to read: +23 min

Novo spent at least $25.8 million over the past decade on U.S. medical professionals to promote its two obesity drugs, Wegovy and Saxenda, the analysis found. Jastreboff has also worked on clinical trials of obesity drugs for Eli Lilly, which markets a Wegovy competitor. Some doctors said Novo’s payments exemplify how the flood of industry money can dominate decision-making about care and coverage. Government pharmacy officer Solaru said her agency concluded that the new obesity drugs could be cost-effective by preventing other weight-related diseases and boosting workplace productivity. In January, the personnel office told its health plans they must cover at least one GLP-1 obesity drug for 8 million workers, retirees and family members.

Persons: Lee Kaplan, Kaplan, ”, gastroenterologist, He’s, Novo, Donna Ryan, Ryan, “, ” Kaplan, ” Novo, Robert Lustig, “ I’m, Lustig, They’re, Ania, ” Jastreboff, Jastreboff, Eli Lilly, Lilly’s Zepbound, Lilly, ” Lilly, Novo’s, Ayana, Sanders, Arthur Kellermann, ” Kellermann, mouthpieces, ’ ”, “ I'm, Jamy Ard, Ard, Dele, ” Solaru, ” Ryan, Scott Kahan, Kahan, Solaru, Christine Gallagher, Wegovy, Rebekah Carl, Carl, Jen Wexler, gaunt, Wexler Organizations: Novo Nordisk, Dartmouth, Nutrition Institute, Massachusetts General Hospital, Harvard Medical School, Reuters, Cambridge, Obesity Society, U.S ., Management, Reuters . Pharmaceutical, ”, U.S, United, National Health Service, University of California, U.S . Food, Drug Administration, Doctors, Wegovy’s, BMI, Yale University’s Center, Weight Management, Wall Street, American Medical Association, Rutgers University’s School of Public Health, Affordable, . Pharmaceutical, Companies, Uniformed Services University of Health Sciences, Wake Forest University, Wake Forest Baptist Health Weight Management, Obesity, Pennington Biomedical Research, U.S . National Institutes of Health, Personnel Management, Coalition, STOP, George Washington University, Novo Locations: CAMBRIDGE, Massachusetts, Boston, U.S, Novo, Danish, United States, Louisiana, San Francisco, Wegovy, Pennington, Baton Rouge , Louisiana, Government, New Columbia , Pennsylvania, Florida

[1/4] Employees work in the manufacturing of Pfizer’s new respiratory syncytial virus (RSV) vaccine Abrysvo, in this undated handout picture. Pfizer/Handout via REUTERS Acquire Licensing RightsWASHINGTON, Nov 28 (Reuters) - Senior Biden administration officials met with RSV vaccine makers this week to underscore the need for manufacturers such as Sanofi (SASY.PA) and AstraZeneca (AZN.L) to urgently meet demand as winter approaches, the White House said on Tuesday. At a meeting at the White House on Monday, officials and manufacturers also agreed to plan now to meet next year's demand for the vaccines targeting respiratory syncytial virus, which generally causes mild, cold-like symptoms but can develop into severe illness in infants and older adults. "Monday's meeting follows numerous in-person and virtual meetings to seek ways manufacturers can make more RSV immunizations available for infants," the White House said in a statement. Reporting by Susan Heavey and Ahmed Aboulenein; Additional reporting by Mike Erman; Editing by Katharine Jackson and Nick ZieminskiOur Standards: The Thomson Reuters Trust Principles.

Persons: Susan Heavey, Ahmed Aboulenein, Mike Erman, Katharine Jackson, Nick Zieminski Organizations: Pfizer, Handout, REUTERS Acquire, Rights, Biden, Sanofi, AstraZeneca, White, U.S . Centers for Disease Control, Prevention, CDC, Thomson Locations: U.S

NASHVILLE, Tenn. (AP) — A ransomware attack has prompted a health care chain that operates 30 hospitals in six states to divert patients from at least some of its emergency rooms to other hospitals, while putting certain elective procedures on pause, the company announced. All of its hospitals are continuing to provide medical screenings and stabilizing care to patients arriving at emergency rooms, the company said. Ransomware criminals do not usually admit to an attack unless the victim refuses to pay. Education was the sector most likely to be hit, with attack saturation at 80%. While industries across the spectrum have been hit by ransomware, a recent attack on China’s biggest bank that affected U.S. Treasury trading represented a rare attack on a financial institution.

Persons: Sophos, Brett Callow, Emsisoft, ”, “, ” “ We’re, ” Callow, Frank Bajak Organizations: Ardent Health Services, Ardent, ”, Treasury, Associated Press Locations: Tenn, Nashville , Tennessee, Oklahoma , Texas , New Jersey, New Mexico , Idaho, Kansas, U.S, Soviet

☆ Jeremy Grantham's GMO just launched an actively managed fund focused on high-quality stocks. Its manager shares 7 unique companies he's betting on to deliver high returns.
▼ + stars: | 2023-11-24 | by ( William Edwards | ) www.businessinsider.com time to read: +4 min

The GMO US Quality ETF (QLTY) launched on November 12, and as its name implies, the fund seeks to offer investors exposure to so-called quality stocks through an actively managed approach. This story is available exclusively to Business Insider subscribers. "At GMO, internally we also talk about intrinsic value, which is adjusting for growth and quality," Hancock said. The aerospace business manufactures and re-services airplane engines, and the continued resurgence in global demand for travel following the pandemic bodes well for the business, Hancock said. While the timing of the ETF release is not related to Grantham's call, Hancock said quality stocks are typically more defensive in a recessionary environment.

Persons: Tom Hancock, Hancock, Jeremy Grantham, Grantham Organizations: Business, Microsoft, Apple, Nvidia, Electric, GE

REUTERS/Evelyn Hockstein/Illustration Acquire Licensing RightsWASHINGTON, Nov 20 (Reuters) - The U.S. government on Monday will start taking orders for another round of free COVID-19 tests for delivery across the country, a Department of Health and Human Services (HHS) spokesperson said. Households that had ordered four free tests through COVIDTests.gov when they were offered again in September are eligible to order four more, while those that did not can submit two orders for a total of eight free tests. It resumed offering the tests in December 2022 as cases were surging, and opened another round of orders on Sept. 25 this year. The tests are paid for using COVID-19 supplemental funding from the American Rescue Plan, the HHS spokesperson said. HHS and the Department of Education plan to expand a program that brings tests to schools nationwide over the coming weeks.

Persons: Evelyn Hockstein, Joe Biden's, Biden, Ahmed Aboulenein, Bill Berkrot Organizations: District of Columbia, REUTERS, Rights, U.S, of Health, Human Services, Centers for Disease Control, Prevention, American, HHS, Department of, Thomson

The logo of Lilly is seen on a wall of the Lilly France company unit, part of the Eli Lilly and Co drugmaker group, in Fegersheim near Strasbourg, France, February 1, 2018. REUTERS/Vincent Kessler Acquire Licensing RightsNov 17 (Reuters) - Retail flows into Eli Lilly (LLY.N) spiked to a more than two-year high in November, as small investors rushed to buy the stock after the U.S. pharma major received a highly anticipated approval for its weight-loss drug Zepbound. Lilly and Novo Nordisk (NOVOb.CO) - seen as leaders in a potential $100 billion obesity treatment market - have helped rekindle retail investor interest in the healthcare sector. "During the COVID period, retail investors were piling into healthcare because of the vaccines and after that there was a bit of a hangover of purchases. Reuters GraphicsRetail investors are now "catching up" with institutional investors, said Sel Hardy, vice president of equity research at CFRA.

Persons: Lilly, Eli Lilly, Vincent Kessler, Zepbound, Marco Iachini, Hardy, JPMorgan Chase, Vanda, Ozempic, drugmakers, Iachini, Bhanvi Satija, Sriraj Organizations: REUTERS, U.S . pharma, Vanda Research, Novo Nordisk, Graphics Retail, Sel Hardy, JPMorgan, BlackRock, AMC, Thomson Locations: Lilly France, Fegersheim, Strasbourg, France, U.S, Bengaluru

A New York City woman who died Sunday from cancer has raised enough money to erase millions of dollars in medical debt with a posthumous plea for help. The posts included a link to a fundraising campaign started through the nonprofit RIP Medical Debt. It had raised about $140,000 by Friday afternoon, or enough to buy around $14 million in medical debt. RIP Medical Debt erases debt purchased from hospitals, other health care providers and the secondary debt market. They were inspired by a video they saw of North Carolina churchgoers burning about $3 million in medical debt.

Persons: Casey McIntyre, McIntyre, ” “, Andrew Rose Gregory, Gregory, Casey, ”, Daniel Lempert, Grace, “ Casey, ” Gregory Organizations: York City, Memorial Sloan Kettering Cancer Center, North, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: York, U.S, Brooklyn, North Carolina

☆ It's open enrollment season for health coverage. If you're self-employed, you can't afford to ignore it
▼ + stars: | 2023-11-13 | by ( Cheryl Winokur Munk | ) www.cnbc.com time to read: +6 min

Picking health insurance on your own — without the help of a human resources department — can be daunting. Instead of throwing up your hands in frustration, here are answers to questions self-employed individuals often have about open enrollment. Doing nothing will mean they are automatically reenrolled in last year's marketplace plan. How much health insurance costs the self-employed Cost will vary, depending on the plan you choose, who is covered and what subsidies you're eligible for. If you want more specific help, you can also choose to work with an agent or broker who is trained and certified to sell marketplace health plans in the state they are licensed.

Persons: Anthony Lopez, Alexa Irish, Laura Speyer, enrollees, Lopez, You'll Organizations: Getty, Centers, Medicare, Medicaid Services, U.S . Department of Health, Human Services, deductibles, state's Department of Insurance Locations: trepidation, eHealth

☆ Eli Lilly and more: Strategist names 5 stocks set for 'significant' earnings growth
▼ + stars: | 2023-11-10 | by ( Amala Balakrishner | ) www.cnbc.com time to read: +4 min

Rising rates and the possibility of a recession on the horizon have created a "mixed picture" for equity markets, according to one strategist — but several companies can look forward to markedly stronger earnings growth in the next year. "But, if you're looking for significant earnings expansion, I suspect, at a market level, that's probably less likely. The earnings growth rate for the S & P 500 was 3.7% year-on-year – the first quarter with year-on-year growth since the third quarter of 2022, the data showed. "What Eli Lilly is going to do with their weight loss drug is not dependent on whether the rates are 5.2% or 4.8%. "People didn't really talk about [Adobe] — everyone assumed that they were going to be a loser from AI," he said.

Persons: —, they're, Rahul Ghosh, Rowe Price, Ghosh, Eli Lilly, Powell, Software Ghosh, — CNBC's Annika Kim Constantino Organizations: Healthcare Healthcare, UnitedHealth Group, Fellow, Food and Drug Administration, Software, Adobe Creative, Adobe Express

Search resuls for: ". Healthcare"

25 mentions found